Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Matthew Hotopf, PhD, MRCPsych
JCP
Original Research
Autism and Antipsychotic Treatment
November 7, 2017
Read this article to see if the presence of ASD limited the effectiveness of antipsychotic treatment in youth with ASD and psychosis.
Matthew Hotopf
,
Johnny M. Downs
,
Suzannah Lechler
, et al
JCP
Original Research
Are All Antidepressants Really the Same? The Case of Fluoxetine: A Systematic Review
June 15, 2006
Corrado Barbui
,
Andrea Cipriani
,
Paolo Brambilla
, et al
JCP
Original Research
Quality of Life in Schizophrenia: A Multicenter, Randomized, Naturalistic, Controlled Trial Comparing Olanzapine to First-Generation Antipsychotics
July 15, 2005
Matthew Hotopf
,
Alan Breier
,
Maurício Silva de Lima
, et al
